TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $37 | -99.9% | 2,515 | -19.5% | 0.00% | – |
| Q3 2022 | $38,000 | -11.6% | 3,125 | -1.2% | 0.00% | – |
| Q2 2022 | $43,000 | -63.9% | 3,163 | -62.7% | 0.00% | -100.0% |
| Q1 2022 | $119,000 | +260.6% | 8,482 | +230.4% | 0.00% | – |
| Q4 2021 | $33,000 | -38.9% | 2,567 | -24.1% | 0.00% | – |
| Q3 2021 | $54,000 | +20.0% | 3,380 | +24.8% | 0.00% | – |
| Q2 2021 | $45,000 | -2.2% | 2,709 | +5.4% | 0.00% | – |
| Q1 2021 | $46,000 | +31.4% | 2,569 | +30.3% | 0.00% | – |
| Q4 2020 | $35,000 | -25.5% | 1,971 | -26.5% | 0.00% | – |
| Q3 2020 | $47,000 | +27.0% | 2,683 | +30.3% | 0.00% | – |
| Q2 2020 | $37,000 | -7.5% | 2,059 | -21.2% | 0.00% | -100.0% |
| Q1 2020 | $40,000 | -88.8% | 2,614 | -85.5% | 0.00% | -75.0% |
| Q4 2019 | $357,000 | +9.2% | 18,068 | -5.2% | 0.00% | 0.0% |
| Q3 2019 | $327,000 | -0.3% | 19,050 | +2.9% | 0.00% | -20.0% |
| Q2 2019 | $328,000 | -73.0% | 18,511 | -69.0% | 0.01% | -70.6% |
| Q1 2019 | $1,216,000 | – | 59,687 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |